Press Releases Year None202220212020201920182017201620152014 Feb 10, 2022 Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference Keep Reading Feb 09, 2022 Twist Bioscience Announces Proposed Public Offering of Common Stock Keep Reading Feb 08, 2022 C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection Keep Reading Feb 07, 2022 Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools Keep Reading Feb 04, 2022 Twist Bioscience Reports First Quarter 2022 Financial Results Keep Reading Feb 01, 2022 Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications Keep Reading Jan 31, 2022 Twist Bioscience Releases Inaugural ESG Report Highlighting Achievements and Initiatives in Diversity and Sustainability Keep Reading Jan 25, 2022 Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics Keep Reading Jan 20, 2022 Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022 Keep Reading Jan 10, 2022 Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference Keep Reading First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last » Print Page Email Page Email Alerts RSS Feeds
Year None202220212020201920182017201620152014 Feb 10, 2022 Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference Keep Reading Feb 09, 2022 Twist Bioscience Announces Proposed Public Offering of Common Stock Keep Reading Feb 08, 2022 C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection Keep Reading Feb 07, 2022 Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools Keep Reading Feb 04, 2022 Twist Bioscience Reports First Quarter 2022 Financial Results Keep Reading Feb 01, 2022 Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications Keep Reading Jan 31, 2022 Twist Bioscience Releases Inaugural ESG Report Highlighting Achievements and Initiatives in Diversity and Sustainability Keep Reading Jan 25, 2022 Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics Keep Reading Jan 20, 2022 Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022 Keep Reading Jan 10, 2022 Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference Keep Reading First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last »
Feb 10, 2022 Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference Keep Reading
Feb 08, 2022 C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection Keep Reading
Feb 07, 2022 Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools Keep Reading
Feb 01, 2022 Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications Keep Reading
Jan 31, 2022 Twist Bioscience Releases Inaugural ESG Report Highlighting Achievements and Initiatives in Diversity and Sustainability Keep Reading
Jan 25, 2022 Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics Keep Reading
Jan 20, 2022 Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022 Keep Reading
Jan 10, 2022 Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference Keep Reading
